Market Place
Sourcing Support
AnnoraPharma`s Generic Brivaracetam Receives Tentative Approval in the U.S
24 May 2024 //
FDA
MSN Lab`s Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
MSN Laboratories` Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
Apotex`s Generic Brivaracetam Receives Approval in the U.S.
06 Nov 2023 //
FDA
Aurobindo`s Generic Brivaracetam Receives Approval in the U.S.
06 Jan 2023 //
FDA
Lupin`s Generic Brivaracetam Receives Approval in the U.S.
20 Dec 2022 //
FDA
Zydus`s Generic Brivaracetam Receives Approval in the U.S.
03 Oct 2022 //
FDA
Apotex`s Generic Brivaracetam Receives Tentative Approval in the U.S.
12 Jul 2022 //
FDA
Positive MHRA decision for Briviact
23 Jun 2022 //
PHARMATIMES
Aurobindo Pharma Limited Generic Brivaracetam Receives Approval in the U.S.
13 Jun 2022 //
FDA
Sunshine Generic Brivaracetam Receives Approval in the U.S.
09 Jun 2022 //
FDA
Mylan Labs Generic Brivaracetam Receives Approval in the U.S.
07 Jun 2022 //
FDA
UCB Announces BRIVIACT® (brivaracetam) CV Now FDA-Approved
30 Aug 2021 //
PRNEWSWIRE
Lupin receives US FDA tentative approval for generic Briviact tablets.
17 Aug 2021 //
PHARMABIZ
Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets
16 Aug 2021 //
NDTV
Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug
14 Jun 2021 //
BUSINESS STANDARD
Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets
14 Jun 2021 //
BUSINESS STANDARD
NATCO launches Brivaracetam tablets in India
26 Feb 2021 //
EXPRESS PHARMA
Natco Pharma launches epilepsy treatment drug Brivaracetam in India
25 Feb 2021 //
ECONOMIC TIMES
Health Canada Approves BRIVLERA® (brivaracetam) to treat partial-onset seizures
29 Jul 2020 //
NEWSWIRE
UCB Announces New Data from its Epilepsy Portfolio on the AmericanNeurology
25 Jun 2020 //
PRNEWSWIRE
UCB Presents New Data Demonstrating Commitment to Epilepsy
05 Dec 2019 //
PR NEWSWIRE
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
UCB’s antiepileptic drug gains new US indication
20 Sep 2017 //
PMLIVE
New indication for BRIVIACT brivaracetam, UCB`s newest antiepileptic drug approv
14 Sep 2017 //
PR NEWSWIRE
UCB seeks USFDA approval for Briviact CV as monotherapy treatment patients
21 Jan 2017 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.